The role of CYP2C19 poor metabolizers and extensive metabolizers of PPI [proton pump inhibitors] in short-term triple therapy on the eradication of H. [Helicobacter] pylori infection: implication of PK [pharmacokinetic]/PD [pharmacodynamic] relationships
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antibacterials; Esomeprazole; Rabeprazole
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- 23 Nov 2005 Biomarkers information updated
- 06 Nov 2005 New trial record.